Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Regulating medical devices
- Latest information for patients
- About MHRA
- All MHRA services and information
Featured
Minister visits MHRA to see cutting-edge science protecting patients and supporting the NHS
Press release
The MHRA welcomed Health Minister Smyth to its science campus as part of British Science Week to demonstrate how innovations become safe, effective treatments for NHS patients.
Triple combination medicine deutivacaftor/tezacaftor/vanzacaftor approved for cystic fibrosis
Press release
As with all products, the MHRA will keep its safety under close review
Lazertinib approved for use in combination with amivantamab for the treatment of adults with non-small cell lung cancer
Press release
As with all products, the MHRA will keep its safety under close review.
New study shows MHRA collaboration with hospital DNA sequencing service cuts time to diagnose infections
Press release
In a UK-first, the Medicines and Healthcare products Regulatory Agency (MHRA) and Barts Health NHS Trust have developed a DNA sequencing approach that can be implemented onsite in hospitals so they can diagnose bacterial infections faster and more accurately.
Members of the public asked to return Boots Paracetamol 500mg tablets due to packaging error
Press release
People who have purchased Boots Paracetamol 500mg Tablets 16s (Item code 81-99-922, Batch 241005, Expiry date 12/2029) are advised to stop using the product immediately and return it to a Boots store for a full refund, because of a packaging error.
A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk of getting lower respiratory tract disease caused by RSV, compared with those who received placebo.
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Transparency and freedom of information releases
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA10 South Colonnade
London
E14 4PU
United Kingdom
Telephone (including out of hours):
020 3080 7651
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom